Despite the remarkable evolutionary and metabolic diversity found within the human microbiome, the vast majority of mechanistic studies focus on two phyla: the Bacteroidetes and the Proteobacteria. Generalizable tools for studying the other phyla are urgently needed in order to transition microbiome research from a descriptive to a mechanistic discipline. Here, we focus on the Coriobacteriia class within the Actinobacteria phylum, detected in the distal gut of 90% of adult individuals around the world, which have been associated with both chronic and infectious disease, and play a key role in the metabolism of pharmaceutical, dietary, and endogenous compounds. We established, sequenced, and annotated a strain collection spanning 14 genera, 8 decades, and 3 continents, with a focus on Eggerthella lenta. Genome-wide alignments revealed inconsistencies in the taxonomy of the Coriobacteriia for which amendments have been proposed. Re-sequencing of the E. lenta type strain from multiple culture collections and our laboratory stock allowed us to identify errors in the finished genome and to identify point mutations associated with antibiotic resistance. Analysis of 24 E. lenta genomes revealed an "open" pan-genome suggesting we still have not fully sampled the genetic and metabolic diversity within this bacterial species. Consistent with the requirement for arginine during in vitro growth, the core E. lenta genome included the arginine dihydrolase pathway. Surprisingly, glycolysis and the citric acid cycle was also conserved in E. lenta despite the lack of evidence for carbohydrate utilization. We identified a species-specific marker gene and validated a multiplexed quantitative PCR assay for simultaneous detection of E. lenta and specific genes of interest from stool samples. Finally, we demonstrated the utility of comparative genomics for linking variable genes to strain-specific phenotypes, including antibiotic resistance and drug metabolism. To facilitate the continued functional genomic analysis of the Coriobacteriia, we have deposited the full collection of strains in DSMZ and have written a general software tool (ElenMatchR) that can be readily applied to novel phenotypic traits of interest. Together, these tools provide a first step towards a molecular understanding of the many neglected but clinically-relevant members of the human gut microbiome.
Introduction
The isolation and sequencing of genomes from the human microbiome has been a major component of initiatives including the Human Microbiome Project (HMP) and Genomic Encyclopedia of Bacteria and Archaea (GEBA). This has led to the generation of thousands of genomes for the scientific community. These projects have focused on the sequencing of representative strains from the gut, skin, oral cavity, and other body habitats (HMP) (1) and systematically filling in holes in the tree of life (GEBA) (2) . However, by definition these large-scale surveys favor breadth over depth and individual species are often poorly sampled; 60% of species in the HMP collection are represented by a single genome (1) .
Strains of the same bacterial species are usually defined as having shared phenotypic characteristics (3) and, in the genomic era, 95% average nucleotide identity (4) . When combined with the great diversity in gene content between bacterial strains often rendered by horizontal gene transfer (HGT), some have even questioned whether the species concept of bacteria is appropriate (5) . Even isolates of the same strain which should be genetically identical can have meaningful variation affecting host interactions as has been observed with the variable presence of mucin-binding pili in Lactobacillus rhamnosus GG isolates (6) . These observations highlight the importance of sampling the genetic and phenotypic diversity within specific clades of bacteria as a complementary approach to broad surveys. This is especially important for the development of microbiome-targeted diagnostics and interventions wherein low resolution markers are often used to infer genetic and phenotypic traits of communities (7) . Here, we demonstrate the utility of conducting an indepth analysis of a single group of neglected, but clinicallyrelevant bacteria in these collections for which genetic tools are largely lacking. We focus on the Coriobacteriia class and in particular the species Eggerthella lenta due to their broad relevance for human health and disease, but the tools and approaches we describe could be readily applied to other taxonomic groups of interest.
Coriobacteriia are one of the most prevalent bacterial classes in the distal gut of adults, yet its low abundance and difficulty in isolation has led to a lack of biological material and tools for its study. The type genus of Coriobacterium was first isolated from the gut of the red soldier bug (8) . Since then, the remaining genera have been primarily isolated from mammals suggesting a strong tropism for life as an intestinal symbiont (9) . These bacteria, in particular the genera Eggerthella and Paraeggerthella, are often considered opportunistic pathogens due to their common isolation from bacteremia patients (10) (11) (12) . More recently, microbiome surveys have revealed positive associations between these bacteria and type 2 diabetes, cardiovascular disease, and rheumatoid arthritis though causative links remains to be established (13) (14) (15) .
Members of the Coriobacteriia are also versatile in the metabolism of pharmaceutical, dietary, and endogenous compounds. E. lenta, a focus of this work, inactivates the cardiac drug digoxin (16) (17) (18) and metabolizes bile acids (19, 20) . This class also plays a key role in the production of small molecules that are similar to estrogen in their chemical structure and function (referred to as phytoestrogens). E. lenta contributes to the multi-step biotransformation of plant-derived polyphenolic lignans to estrogenlike compounds (phytoestrogens) (21, 22) , whereas Slackia isoflavoniconvertens, a close relative, metabolizes the plantderived isoflavone daidzein to the phytoestrogen equol and 5-hydroxy-equol (23) The primary goal of this work was to assemble a collection of isolates from the Coriobacteriia, and in particular the species E. lenta, to be sequenced and made publicly available to facilitate improved understanding of this understudied but clinically-relevant group of human gut bacteria. Through the use of these genomes, we have designed an assay for the sensitive and selective quantification of E. lenta and its effectors from fecal samples. In addition to releasing their genome sequences, a user-friendly tool, ElenMatchR has been developed to facilitate gene-trait matching experiments (jbisanz.shinyapps.io/elenmatchr/) which we validate by uncovering antibiotic resistance genes naturally occurring within the E. lenta species and with previously described genes for drug inactivation (16, 18) .
Results and Discussion
Genome Sequencing. Through public collections (n=22), and novel isolation (n=28), we collected 50 isolates for study (Supplemental Table 1 ). This collection represents 14 constituent genera of the Coriobacteriia (9, 24) including 30 Eggerthella lenta isolates. While most isolates were derived from human-associated communities, a single isolate is derived from the murine cecum (Parvibacter caecicola DSM 22242). Strains range in year of isolation from 1938 to 2016 and represent 8 countries over 3 continents from regions of variable Coriobacteriia prevalence in human gut microbiomes ranging from 86.8 to 96.4% (Supplemental Figure  1 ). Of these 50 isolates, 33 were without a sequenced public genome leading to us to initiate a sequencing project over the course of multiple years using variable sequencing strategies as new strains became available. A total of 33 new highquality draft genomes were generated (62 ± 18 total scaffolds, 152 ± 62 kb N50, 8.6 ± 2.4 scaffolds L50 [mean ± sd]). More complete genome assembly statistics are available on a per-genome basis in Supplemental Figures 2AB,  and Supplemental Table 2 . Genomes were considered to be free of contaminants based on pre-assembly filtering sequencing reads for human, phiX174, and Illumina/NEBNext adapter sequences (see methods), and an approximate Gaussian distribution in GC content (Supplemental Figure 2C ). In the process of analysis, an additional public genome (Clostridium difficile F501: PRJNA85919) was uncovered sharing significant nucleotide homologies to E. lenta. On closer inspection, it was determined on the basis of GC distribution and 16S rRNA content, that this genome is heavily contaminated by high GC content DNA consistent with an E. lenta strain (Supplemental Figure 3 ). Recovery of 16S rRNA sequences from contigs had 100% identity to E. lenta DSM 2243 and 99% identity to Parabacteroides distasonis ATCC 8503 suggesting an impure DNA preparation. The genome has been flagged as an anomalous assembly; however, an issue that is being repaired by Genbank staff resulted it in still appearing in BLAST databases. This contamination has led to inappropriate conclusions by other groups who would be justly unaware of this contamination (25) . Taxonomic and phylogenetic description. The taxonomy of the Coriobacteriia was recently amended separating the constituent members into 3 families that were formerly all within the Coriobacteriaceae to include the additional families Eggerthellaceae and Atopobiaceae (24) . This analysis reflects the current list of prokaryotic names with standing nomenclature (26) . Given that many of the strains sequenced were not originally assigned a species (examples: DSM 11767 and DSM 11863) or were novel isolates, we sought to validate their taxonomy on the basis of genome-wide average nucleotide identity (ANI). ANI is an in silico alternative to traditional DNA-DNA hybridization (DDH) wherein 95% ANI is generally accepted as the species boundary corresponding to 70% DDH. All strains of E. lenta (taxonomy based on 16S rRNA sequence or culture collection identification) were confirmed with ANI varying from between 97.98 to 99.64% (98.65 ± 0.32 mean ± sd) within the species E. lenta, and 81.96 to 91.40% (84.83 ± 1.94) to isolates outside the species ( Figures 1AB) . ANI was also applied in combination with isolation metadata to dereplicate isolates removing suspect clonal isolates (>99.999% ANI, n=3 strains with clonal isolates, n=24 total dereplicated strains). This analysis highlights an issue relating to the assignment of the Eggerthella YY7918 strain to its genus given the lack of homology to Eggerthella genus (84.50 to 87.21%, 85.88 ± 1.01 mean ± sd). Its location in a phylogenetic tree also clearly positions it outside of the genus ( Figure 1C ) and its GC content is only 56% deviating far from the 64% and 65% of E. lenta and E. sinensis. Given these data, and the nearest match of 93% to Gordonibacter spp. by 16S rRNA sequence, it is proposed that Eggerthella YY7918 represents a novel genus for which it is the type species. The inclusion of this genome into databases for taxonomic assignment of short reads from microbiome studies, including the default database for MetaPhlAn2 (27) , may lead inappropriate inferences of abundances of the Eggerthella genus.
We also report a close similarity between the genera Asaccharobacter and Adlercreutzia (Figures 1AB, Supplemental Table 3 ), two genera described in May 2008 (28, 29) , and whose type species' partial 16S rRNA sequences share 99% identity with 99% coverage (Genbank accessions: AB306661 and AB2666102). This suggests the existence of these two separate genera is inappropriate and that they should be collapsed to a single genus. Due to these discrepancies in the accepted nomenclature, strains AP38TSA and OB21GAM11 have been deposited with their original taxonomic identification of Asaccharobacter celatus. Identification of intra-isolate genetic polymorphisms. The type strain of E. lenta (DSM 2243 = ATCC 25559 = VPI 0255 = 1899 B) was first sequenced by Saunders et al. in 2009 (30) using a combination of Sanger and pyrosequencing as part of the GEBA project (2) . Given that phenotypically relevant genetic mutations can occur between isolates of the same strain (6), we resequenced our laboratory strain of DSM 2243 (referred to herein as UCSF 2243), and fresh isolates from the ATCC and DSMZ culture collections, comparing them to the original contiguous reference assembly of Saunders et al. (30) . All strains were sequenced at ultra-high depth and resulting reads were mapped against the reference assembly demonstrating that no elements have been lost from the genome (median per-base coverage of 391, range 33 to 5942; Figure 2A ). Elevated coverage was observed in the region around a putative prophage (3.02-3.06 Mbp) suggesting an active prophage is present in all 3 stocks.
Next, the alignments were used to call variants between the newly sequenced strains and the reference sequence (Figures 2BC, Supplemental Table 4 ). A total of 5 polymorphisms were found in all sequenced isolates and it is likely that these represent errors in the reference sequence ( Figure 2C ). 3 of 5 shared polymorphisms are insertion/deletions in homopolymeric runs which is indicative of 454-type error while a single missense variant is found in the DNA polymerase III betasubunit. Interestingly, the ATCC isolate contains a missense variant in a putative beta-lactamase (Elen_1788) resulting in a glycine to aspartic acid substitution outside of the predicted beta-lactamase domain (Pfam: PF00144). A literature review of antibiotic susceptibility analyses and treatment of Eggerthella-associated infections suggested that the beta-lactam antibiotics penicillin G and ampicillin have been used for treatment (Supplemental Table 5 ) leading us to examine the relevance of this SNP. We found that this variant in the ATCC 25559 strain was associated with a modest 2-4 fold increase in the minimum inhibitory concentrations of both penicillin Table 6 ). According to the current clinical guidelines (31) , this subtle shift would be sufficient to conclude that the ATCC 25559 isolate is resistant to penicillin G while the other two isolates are not. Further genetic studies are necessary to validate the causal role of this mutation in the antibiotic resistance phenotype, but these data emphasize the difficulties of relying on publicly available reference genomes for functional studies. Analysis of core and variable genes within Eggerthella lenta. To facilitate comparative genomic analysis, we analyzed gene content across the E. lenta strain collection by clustering all predicted coding sequences into orthologous groups (OGs) (32) . Rarefaction analysis suggests an open (unsaturated) pan-genome ( Figure 3A) with >5,871 OGs and a core of 1,832 OGs. At 24 dereplicated E. lenta isolate genomes, 74 new OGs (range:16-178) were discovered with each additional genome sequenced. To reconstruct core and variable metabolic pathways, we mapped the pan-genome to curated KEGG orthologous groups (KOs) with 44.3% of genes across the collection being assigned to an orthology (Supplemental Figure 4) . Metabolic reconstruction of the E. lenta core genome questions the proposed reliance of this bacterium on amino acid catabolism for growth. As expected, the arginine dihydrolase (or arginine deiminase) pathway was present in all strains which explains the need for arginine supplementation to promote in vitro growth (16) . However, the entire backbone of glycolysis was conserved along with all but 1 enzyme of the citric acid cycle (Supplemental Figure 4) . Further more, genes including GAPDH are amongst the most highly expressed genes during exponential growth as measured by RNA-seq (16) . These results conflict with growth assays suggesting that E. lenta is asaccharolytic (30) . Metabolomic and isotope tracking studies are necessary to more definitively test the activity of these enzymes during in vitro or in vivo growth, and the relative contributions of carbohydrate versus amino acid metabolism to cellular metabolism.
G and ampicillin (Supplemental
Another notable pathway within the E. lenta core genome is predicted to convert isoprenoids into the carotenoid lycopene (Supplemental Figure 4 ). This pathway could provide the molecular basis for the production of a red-brown pigment in E. lenta colonies (Supplemental Figure 5 ). In practice, the formation of the pigment is highly variable in the laboratory; however, if the factors that regulate carotenoid production could be known, this feature may help in the more rapid isolation of additional strains as no selective media are currently available (9) . Furthermore, bacterial biosynthesis of carotenoids in the gastrointestinal tract may have important downstream consequence for host pathophysiology (33) . Analysis of the variable component of the E. lenta genome highlighted multiple genomic islands indicative of extensive horizontal gene transfer (HGT) within this bacterial lineage. Genome-wide mapping of each strain against the type strain revealed multiple large-scale gene gain/loss events ( Figure  3C ). Two regions of interest (ROI1 and ROI2, Figure 3C ) reflect potential hot spots of HGT. The 150 Kbp ROI1 contains a type IV secretion system (1.08 Mbp) implicated in HGT and virulence (34) in addition to a TN916 transposase, recombinase, and phiRv2 integrase. The region has partial homology to many other strains of E. lenta but also to S. isoflavoniconvertens, Gordonibacter spp., and Senegalemassilia anaerobia indicative of both intra-species and intra-class HGT. The 54 Kbp ROI2 has been previously described due its association with an 8 bp GAGTGGGA motif recognized by P4 integrases present within a host GMP synthase gene (35) . It is associated with genes involved in transposase activity and metal-resistance. ROI3 contains a strain-variable Type I-C CRISPR-cas machinery. ROI4 is home to the digoxinmetabolizing cgr operon (16, 18) and ROI5 contains a putative E. lenta prophage. As an initial step towards developing selective markers for E. lenta genetic manipulation, we searched for antibiotic resistance genes found in only a single strain. We identified a gene with perfect sequence similarity to kanamycin Table 7 ). E. lenta is detectable along the entire length of the gastrointestinal tract with highest levels observed in the colon and cecum. Points represent individual animals (n=6-10/group) and lines represent mean±SEM.
kinase (aminoglycoside phosphotransferase, antibiotic resistance ontology 300264). This gene (referred to herein as E. lenta aph) was unique to E. lenta DSM 11767, which had significantly increased kanamycin resistance relative to the rest of the strain collection (Supplemental Table 5 ). Heterologous expression of E. lenta aph in E. coli resulted in an induction dose-dependent increase in antibiotic resistance ( Figure  3D) . Kanamycin resistance is widely used as a marker for bacterial genetics, making this gene a valuable addition to our growing genetic toolkit for E. lenta. Development of a duplexed assay for quantifying E. lenta species and gene abundance. Given the absence of a selective and/or differential culture media for E. lenta and the expensive, often low resolution, and time-consuming nature of taxonomic identification by 16S rRNA gene and shotgun metagenomic sequencing, we sought to develop a highly sensitive qPCR-based assay for E. lenta. This assay should simultaneously quantify E. lenta and the cgr2 gene, which is responsible for the inactivation of the cardiac drug digoxin (18) , with the ability to be combined with other effectorspecific probes. In this way, we could develop a rapid, affordable, and sensitive assay that could be used to estimate E. lenta abundance and help to estimate the drug-metabolizing capacity of each individual's microbiome. To accomplish these aims, a multiplexed double-dye probe assay was designed. We used our comparative genomics approach to identify single-copy chromosomal genes that could serve as surrogate markers of the E. lenta strains by screening for highly conserved genes present in E. lenta but absent in the remainder of the Coriobacteriia and reporting no hits in the NCBI non-redundant database to other species. This led to the identification of a gene we termed elnmrk1, a luxR family transcriptional regulator (Elen_1291, ACV55260.1). Using a curated collection of processed shotgun metagenomes (36) , we analyzed the correlation between elnmrk1 and E. lenta mOTU (metagenomic operational taxonomic unit) abundance (37) . We found a strong correla-tion (r=0.97 Pearson correlation, Figure 4A ) validating that it is an appropriate surrogate marker for quantification. There is also not strong evidence of an elnmrk1 negative E. lenta population. qPCR primer and probes (Supplemental Table  7 ) were designed to both elnmrk1 and cgr2 and were validated against a dilution series of a pure culture of E. lenta DSM 2243 ( Figure 4B) as well as deeply-sequenced human metagenomes that had previously been taxonomically analyzed ( Figure 4B inset) . While the DNA extraction method will impact recovery and detection, the demonstrated method using mechanical lysis and magnetic bead recovery yielded linear recovery of pure cultures down to nearly 100 CFU/mL. Even in the presence of a second more highly abundant and easily lysed organism (E. coli K12 MG1655), sensitive quantification was possible without specificity issues commonly associated with 16S rDNA targeting assays. We next used this assay to quantify E. lenta DSM 2243 along the GI tract of both mono-colonized and 10-member mock-community colonized Swiss Webster mice. This analysis demonstrates that E. lenta can colonize along the entire murine GI tract, albeit at very low abundances ( Figure 4C) . The composition of the mock community (as determined from V4 16S rRNA gene amplicon sequencing and total 16S rRNA qPCR) is given in Supplemental Table 8 providing corroboration of the qPCR results. These data and Figure  4A indicate that E. lenta is found predominantly at very low abundance in both humans and mice, which may explain why its prevalence has been so underestimated in the microbiome. Both qPCR-and metagenome-based prevalence estimates indicate that the E. lenta is a prevalent member of the human gut microbiome: 74.7% and 41.5%, respectively (18) . Given the clear spectrum of colonization by E. lenta, we are actively pursuing the genetic and environmental determinants which govern colonization by this species. Gene-phenotype matching in E. lenta via comparative genomics. A major motivation for assembling this collection of strains and genomes was to facilitate the discovery of new effectors of metabolism of pharmaceutical, dietary, and endogenous compounds. To make this resource available to the scientific community, the approach and database from which it draws have been made publicly available via a tool we describe as ElenMatchR (jbisanz.shinyapps.io/ElenMatchR). Drawing on the logic of other tools such as PhenoLink (38) , gene presence/absence is binarized/dereplicated, and used as the input predictor variable for a random forest classifier against user-provided phenotypes or traits (Supplemental Figure 7 ). Random forests are advantageous when data is particularly noisy and/or gene networks or multiple effectors are present. At the current time only categorical phenotypes are accepted; however, regression will be supported for continuous phenotypes in the future. The predictive importance (mean decrease in gain in node impurity), is used to extract and rank features. The results of the classifier are returned in addition to: (i) a scatter plot of feature accuracy, (ii) a heat map of gene presence and absence, (iii) candidate nucleotide and amino acid sequences, and (iv) a visualization of the phenotype on a pan-genome and phylogenetic tree.
For a test dataset, since we were aware of pre-existing variation in antibiotic resistance patterns to kanamycin, we opted to assay well-described phenotypes and effectors of antibiotic resistance using both broth microdilution minimal inhibitory concentration assays and Epsilometer (Etest) strips. Antibiotics were selected based on a literature review of susceptibility testing and clinically relevant antibiotics (Supplemental Table 5 ) leading to the screening of 8 antibiotics that are useful for genetic engineering and/or clinically use including the previously mentioned beta-lactams and kanamycin (Supplemental Table 6 ). Tetracycline resistance provided a binary phenotype by broth microdilution ( Figure 5A ) with 10 strains being resistant (MIC>32 µg/mL) and 9 strains being sensitive (MIC=4 µg/mL). This was expanded to 14 resistant strains and 12 sensitive strains via Etests ( Figure  5B ). Using clustering thresholds of 60% amino acid identity and a minimum 80% query coverage for generating orthologous gene clusters (OGs), and after removal of uninformative OGs (present or absent in all strains assayed) a total of 8,853 OGs were considered. After collapsing cooccuring OGs, 1,150 features were used as the input for the classifier. On inspecting variable importance, it is clear that a single OG (3652) provides the most discriminative value between classes ( Figure 5C ). Visualization of presence/absence shows that it is present in all 14 resistant strains, but absent in all sensitive strains ( Figure 5D ). Further analysis of this orthologous cluster of genes, annotated as tetracycline resistance protein TetO, shows that it is comprised of two subclusters with 67.3% amino acid identity to each other ( Figure 5E ). All 14 tetracycline resistance proteins were then annotated against the Comprehensive Antibiotic Resistance Database revealing the two subclusters to represent the related tetO and tetW ribosomal protection proteins with an average blast identity of 99.4% (range 98.28 to 99.7, ARO 3000190 and 3000194 respectively) (39) . To validate this gene, a putative tetW from E. lenta DSM 11767 was cloned under the T7-lac promoter of pET19btev to be heterologously expressed in E. coli Rosetta. Expression of tetW conveyed resistance to tetracycline ( Figure 5F ) increasing the MICs from 1 µg/mL to ≥ 16 µg/mL in an induction-dose dependent manner. These genes, together with the kanamycin resistance gene identified in our pan-genome analysis, represent suitable antibiotic selection markers for the purposes of establishing tools for the genetic manipulation of E. lenta. Finally, we showed that ElenMatchR can also be readily applied to identify genes for drug metabolism as it correctly identifies the cardiac glycoside reductase (cgr) operon responsible for digoxin reduction (16) as well as an expanded loci with which it co-occurs termed the cgr-associated gene cluster (18) (Supplemental Figure 8) . Both tetracycline resistance and digoxin metabolism datasets are included with ElenMatchR for demonstration purposes.
Conclusions
Mechanistic studies into the basic biology of the Coriobacteriia coupled to translational studies in preclinical animal models and human cohorts are critical to gaining a greater understanding of the role of these intestinal symbionts in human health and disease. The functional genomic tools described herein have been developed to be shared with the greater scientific community. This includes our open source software package ElenMatchR (jbisanz.shinyapps.io/elenmatchr/), the deposition of these genome assemblies to Genbank, and the availability of novel isolates from the German Collection of Microorganisms and Cell Cultures (DSMZ). Our in-depth analysis of the E. lenta pan-genome suggest that we are just beginning to scratch the surface of the genetic and biochemical potential of this species with many more variable genes remaining to be discovered. Despite our partial view of the full microbial genetic and metabolic diversity within this lineage, we have demonstrated the utility of genome mining, comparative genomics, and nucleotideresolution analyses in elucidating the genetic basis of antibiotic resistance and drug metabolism. The identified antibiotic resistance genes provide a valuable first step towards developing tools for the genetic manipulation of Coriobacteriia. By making both the tool, and its pre-computed underlying databases available, we are openly facilitating others to work in this field and to modify the tool as they see fit. Ongoing studies in our lab are focused on using this framework to provide mechanistic insights into the role of E. lenta and other Coriobacteriia in metabolism, immunity, microbial interactions, and host pathways relevant to disease. Translational studies in human cohorts will be facilitated by the development of a sensitive assay for the quantification of E. lenta and genes of interest from stool samples. This assay is a marked improvement from our earlier protocol (16) due to increased sensitivity and specificity as well as the ability to distinguish E. lenta strains within a single reaction. Additional studies are warranted to test the proof-of-principle for using this approach as a rapid diagnostic test to predict drug response. As new genetic effectors are discovered for other host or microbial phenotypes of interest, they could be multiplexed into the current assay for multiple marker detection. Together, these results highlight that moving beyond shallow coverage of gut bacterial taxonomic groups will improve our collective understanding of the role of the microbiome in health and disease. Our data emphasizes that single type strains and their genomes do not represent the broader scope of genotypic and phenotypic diversity within a given clade. In some cases, even single nucleotide polymorphisms appear to have phenotypic consequences, necessitating genomewide nucleotide resolution and routine re-sequencing of culture collections. Progress towards microbiome-based precision medicine will likely require this level of specificity for accurate diagnostic and prognostic markers. More broadly, this work represents a generalizable template for the dissection of additional neglected taxonomic groups with the longterm goal of understanding the molecular mechanisms responsible for changes in the structure and function of hostassociated microbial communities.
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Methods
Strain Isolation and Culture. Novel strains were isolated in multiple medias. Briefly, this includes Eubacterial minimal media supplemented with 1% w/v arginine, 50 µg/mL hygromycin, and 25 µg/mL nalidixic acid; brain heart infusion agar (BHI) supplemented with 1% arginine; fastidious anaerobe agar (FAA); and nutrient agar. All strains were isolated under anaerobic conditions at 37 • C. Routine culturing was carried out under anaerobic conditions (Coy Lab Products) using the appropriate media listed in Supplemental Table 1 . Media used for routine experimentation were BHI+ (BHI with 1% arginine), BHI++ (BHI with 1% arginine, 0.05% L-cysteine-HCl, 1 µg/mL vitamin K, 5 µg/mL hemin, and 0.0001% w/v resazurin), or TSA blood + (tryptic soy agar with 0.5% arginine and 5% sheep blood). Library preparation and sequencing. Genomic DNA was prepared from anaerobic 24 hour liquid cultures using the media described above before extraction using the Powersoil DNA extraction kit (MoBio), PureLink genomic DNA minikit (Ther-moFisher) or DNeasy UltraClean Microbial kit (Qiagen). Libraries were prepared with either an Apollo 324 instrument, the Nextera XT kit (Illumina), or TruSeq PCRfree kit (Illumina). Libraries were sequenced according to the platform and chemistry listed in Supplemental Table 1 . Genome assembly and annotation. Demultiplexed sequences were analyzed first by FastQC before filter human and phiX174 contamination by removing reads that mapped to the hg19 and NC_001422.1 assemblies respectively with Bowtie 2 (40) . Potential adapter contamination was removed using Trimmomatic (41) with additional sliding window filtering. Where paired reads were present, overlaps were assembled using VSEARCH (42) for use as a separate single-ended library for assembly. Assembly was carried out using the SPAdes genome assembler (43) . Assembly statistics were generated using the QUAST quality assessment tool for genomes (44) . Assembled genomes were submitted to NCBI for automated annotation using the Prokaryotic Genome Annotation Pipeline (PGAP). Assembled genomes were also annotated locally for use in comparative genomics analysis using Prokka (45) . These annotated versions (as serialized general feature format files) have been packaged with ElenMatchR and can be extracted using the included unpackgenomes.R script. Phylogenetic analysis was carried out using PhyloPhlAn (46) . Average nucleotide identity was calculated the Pyani package (widdowquinn.github.io/pyani/). Comparative genomic analysis. Clustering of gene orthologs were carried out using ProteinOrtho5 (32) across variable coverage and identity settings. For analysis in this manuscript, a minimal 60% identity and 80% coverage threshold were applied. To carry out gene-trait matching, gene presence was converted to a binary state, and used as the predictor matrix for the randomForest function of the random-Forest package in R. Results were ranked by mean decrease in GINI and plotted. The circular BLAST comparison was generated by splitting the E. lenta DSM 2243 type strain genome into successive 1000 bp ranges and aligning these against all strains (BLAST). These were then plotted in a circular representation colored by nucleotide identity. Genetic variation between DSM 2243 isolates was determined by using the tool Snippy (github.com/tseemann/snippy) and verified using manual inspection of read pileups and breseq (47) . KEGG orthologous group content was assessed using GhostKOALA (48) . Antibiotic resistance screening. Screening was carried out using Epsilometer (Etest) strips (bioMerieux) or broth dilution minimum inhibitory concentration (MIC) assay. For Etest strips, a 24 hour broth culture was diluted to an OD600 of 0.1 before 500 µL was spread on 135 mm plates with 4 strips per plate. The assays used were: CL 256, TC 256, KM 256, AM 256, VA 256, MX 32, PG 32, and MZ 256. Resistance was determined based on EuCAST breakpoint tables (version 8.0 2018) where available (31), or by MIC distribution. For the broth MIC assay, a 24h broth culture was inoculated at 1% v/v in a 96-well plate and incubated in anaerobic conditions at 37 • C for 48h with OD600 recorded by an Eon microplate reader (BioTek). Strains were assayed twice and the mean value reported. Resistance was determined based on the bimodal distribution of MICs. Heterologous expression. The sequences of a putative tetW (DSM11767_02172) and aminoglycoside 3'-phosphotransferase (DSM11767_01344) were amplified from genomic DNA of E. lenta DSM 11767 with Q5 polymerase (NEB) using 500 µM primers ( Supplemental Table 7 ) for 30 cycles. pET19btev (a derivative of pET19b with a tobacco etch virus [TEV] cut site replacing the enterokinase cut site) was used as the expression vector. Both inserts and plasmid were cut with NdeI and BamHI. The plasmid backbone was treated with recombinant shrimp alkaline phosphatase (rSAP) before both plasmid and inserts were gel purified (Qiaquick gel purification kit). Ligation was carried out with T4 ligase. All enzymes for cloning were purchased from New England Biolabs and used according to the manufacturer's instructions. Ligation reactions were heat inactivated and transformed into E. coli DH5α and selected using LB media with 100µg/mL ampicillin. Plasmids were extracted from transformants and confirmed by sanger sequencing (GeneWiz) from the T7 promoter and terminator. Verified plasmids were then transformed into E. coli Rosetta and selected on LB with 50 µg/mL carbpenicillin (for pET19btev) and 30 µg/mL chloramphenicol (for selection of pRARE plasmid carrying rare codons). Verified transformants were then grown in LB broth for 8h with appropriate selection before being inoculated 0.5% v/v across a range of tetracycline, kanamycin, and IPTG concentrations in 96 well plates. Plates were incubated for 16 hours at 37 • C and read at OD600 using an Eon microplate reader (BioTek). Mouse and human samples. Human samples were collected and analyzed as part of a diet-intervention study whose analysis is described elsewhere (clinicaltrials.gov registration: NCT01105143). Human experiments were approved by the ethics committee of the Charité-Universitätsmedizin Berlin. Germ-free Swiss Webster mice were obtained from the UCSF Gnotobiotics core facility (gnotobiotics.ucsf.edu) and housed in gnotobiotic isolators (Class Biologically Clean). For the mono-colonization experiment, each of 10 Swiss Webster mice were orally gavaged with an inoculum of 1E8 CFUs of E. lenta DSM 2243 (prepared in an anaerobic environment and suspended in 200 µL PBS, which contained 0.05% L-cysteine-HCl). Mice were allowed to feed ad libitum on one of two isocaloric, isonitrogenous semi-purified diets composed of 10% sesame seeds (Teklad custom research diet). One diet was supplemented with 0.5% L-arginine (TD.150470) and provided to 5 mice; the other diet contained no supplemented L-arginine (TD.150471) and was provided to the other 5 mice. At 14 days following colonization, mice were euthanized, and the contents from each segment of the GI tract were collected. Arginine levels were not found to impact colonization (p>0.05, linear mixed effects model). For the 10-member mock community, 1E8 CFUs of each member (Supplemental Table 8 ) was combined and 1E8 CFUs (in 200 µL saline + 0.5% cysteine) was administered to 7 germ-free Swiss Webster mice who were given ad libitum accession to food (LabDiet 5021) and water. After 18 days, mice were sacrificed and contents collected from each segment of the GI tract. All mouse experiments were approved by the University of California San Francisco Institutional Animal Care and Use Committee. The mock community was profiled using 515F/806R golaybarcodes (49) and denoised using DADA2 (50) . DNA extraction and qPCR. DNA was extracted from 100 mg aliquots of material using the ZymoBIOMICS 96 MagBead DNA Kit (Zymo D4302) according to the manufacturer's protocol with an additional 10 minute incubation after mechanical cell disruption at 65 • C. Disruption was carried out using a BioSpec Mini-Beadbeater-96 for 5 minutes. qPCR was carried out using Taq Universal Probes Supermix (BioRad 1725131), in a CFX384 thermocycler (BioRad) in triplicate 10 µL reactions with all oligos (Supplemental Table 7 ) present at 200 nM final concentration and 4 µL of purified gDNA. DNA was amplified using 40 cycles of 5 seconds at 95 • C and 30 seconds at 60 • C after 5 minutes initial denaturation at 95 • C. Absolute copies were determined by comparison against a standard curve of E. lenta DSM2243 genomic DNA. The primer efficiencies of the elnmrk1 and cgr2 assays are 105% and 103.5% respectively. A practical limit of quantification of 1400 genome equivalents/ml was determined as it was the last dilution in the series fitting the linear trend-line with concordant detection in all replicate wells.
Supplemental Figures
Supplemental Figure 1 . Isolation locations and Coriobacteriia prevalence. Location of isolation where known is plotted for the strain collection and prevalence of Coriobacteriia (as determined from MetaPhlAn2 analysis of curated shotgun metagenomes (36) ) is plotted where known. Note: Coriobacteriaceae prevalence estimates were used as the MetaPhlAn2 database is based on the previously accepted nomenclature where in all members of the Coriobacteriia were within the family Coriobacteriaceae.
Supplemental Figure 2 . Sequence assembly statistics. High quality draft genomes were generated for newly sequenced strains based on: (A) a small number of contigs per genome (62 ± 18 mean ± sd), and (B) a large contig N50 (length of contig of which >50% genome length is contained in, 152 ± 62 kbp). (C) GC content distribution by genome demonstrates and approximately Gaussian distribution within any given genome indicating genome purity. Figure 2 ), GC content is bimodal and consistent with a high degree of E. lenta in sequenced genomic DNA preparation. Recovery of 16S rRNA sequences from contigs suggests the presence of both E. lenta and P. distasonis in the genome (their average GC contents are denoted by dashed red lines).
Supplemental Figure 5 . Pigmentation in E. lenta DSM 2243. This culture was streaked from frozen glycerol stock on to BHI++ (see methods) and incubated for 72h in anaerobic conditions resulting in a typical red-brown pigment production (inset pellet from 24h anaerobic broth culture in BHI + 1% arginine with E. coli as comparison). Figure 7 . Identification of cardiac glycoside reductase operon by ElenMatchR. (A) Analysis of the occurrence of the top 15 predictive features for digoxin metabolism reveals 8 genes which perfectly co-occur with the ability to reduce digoxin. (B) Using supplied annotation data, it is revealed that the 8 genes occur in a single locus termed which we have term the cgr-associated gene cluster. (C) Occurence of the digoxin reduction phenotype in a phylogenetic tree demonstrates a lack of phylogenetic signal.
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